{
    "organizations": [],
    "uuid": "f003a6976842e83df25b555aa764b991572605bd",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-karo-pharma-ab-q4-adjusted-ebitda/brief-karo-pharma-ab-q4-adjusted-ebitda-rises-to-sek-41-8-mln-idUSFWN1QC0BD",
    "ord_in_thread": 0,
    "title": "BRIEF-Karo Pharma AB Q4 Adjusted EBITDA Rises To SEK 41.8 Mln",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 22 (Reuters) - Karo Pharma Ab:\n* Q4 NET SALES SEK 238.7 MILLION VERSUS SEK 96.5 MILLION YEAR AGO\n* Q4 ADJUSTED EBITDA SEK 41.8 MILLION VERSUS SEK 28.9 MILLION YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-02-22T15:42:00.000+02:00",
    "crawled": "2018-02-23T15:51:37.004+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "karo",
        "pharma",
        "ab",
        "q4",
        "net",
        "sale",
        "sek",
        "million",
        "versus",
        "sek",
        "million",
        "year",
        "ago",
        "q4",
        "adjusted",
        "ebitda",
        "sek",
        "million",
        "versus",
        "sek",
        "million",
        "year",
        "ago",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}